S20-426 An orally, bioavailable, and non-toxic salt to induce DNA demethylation and overcome retinoic acid-resistance in neuroblastoma Dysregulated DNA methylation is associated with poor prognosis in cancer patients, promoting tumorigenesis and therapeutic resistance. Jiangbin Ye Haowen Jiang Yang Li
S18-498 Combination of differentiation therapy and metabolic intervention to treat neuroblastoma Researchers at Stanford have developed a combination therapy to treat neuroblastoma, the most common and deadly solid tumor in childhood. Neuroblastoma derives from neural crest cells that fail to exit the cell cycle and differentiate. Jiangbin Ye Yang Li